| scholarly article | Q13442814 |
| P356 | DOI | 10.1089/TEN.TEA.2010.0557 |
| P8608 | Fatcat ID | release_jqv32biozfh7lb7x6ykjpb5qae |
| P932 | PMC publication ID | 3079173 |
| P698 | PubMed publication ID | 21187004 |
| P2093 | author name string | Thomas N Wight | |
| Charles E Murry | |||
| Pamela Johnson | |||
| Kathleen Braun | |||
| Kareen L Kreutziger | |||
| Veronica Muskheli | |||
| P2860 | cites work | Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. | Q53518426 |
| 2B1 antigen characteristically expressed on extracellular matrices of human malignant tumors is a large chondroitin sulfate proteoglycan, PG-M/versican | Q71381867 | ||
| Gene expression profiling of the functionally distinct human bone marrow stromal cell lines HS-5 and HS-27a | Q74622430 | ||
| Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching | Q81596564 | ||
| Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction | Q83697673 | ||
| Versican degradation and vascular disease | Q24600539 | ||
| Repression of versican expression by microRNA-143 | Q24607134 | ||
| Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue | Q24652369 | ||
| The role of pericytes in blood-vessel formation and maintenance | Q24683881 | ||
| Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts | Q29620480 | ||
| Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds | Q30846050 | ||
| Tissue engineering of vascularized cardiac muscle from human embryonic stem cells | Q33268999 | ||
| Synthesis and organization of hyaluronan and versican by embryonic stem cells undergoing embryoid body differentiation | Q33742788 | ||
| Extracellular matrix, inflammation, and the angiogenic response | Q33795730 | ||
| Tissue engineering of a differentiated cardiac muscle construct | Q34113271 | ||
| Engineering vascularized skeletal muscle tissue | Q34427542 | ||
| Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages | Q34579177 | ||
| Hyaluronan and human endothelial cell behavior. | Q34801813 | ||
| Versican: a versatile extracellular matrix proteoglycan in cell biology | Q34858300 | ||
| Transplantation of a tissue-engineered human vascularized cardiac muscle | Q34994775 | ||
| Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix | Q35033881 | ||
| Hyperproduction of hyaluronan in neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: possible involvement of versican/PG-M. | Q35781386 | ||
| Application of inkjet printing to tissue engineering | Q36581568 | ||
| Macrophages and Tissue Injury: Agents of Defense or Destruction? | Q36896804 | ||
| Engineering vascularised tissues in vitro | Q37089828 | ||
| Prevascularization of cardiac patch on the omentum improves its therapeutic outcome | Q37329635 | ||
| Scaffold-free vascular tissue engineering using bioprinting | Q37356210 | ||
| Scaffold-free human cardiac tissue patch created from embryonic stem cells | Q37414585 | ||
| Athsq1 is an atherosclerosis modifier locus with dramatic effects on lesion area and prominent accumulation of versican | Q37445003 | ||
| Exogenous and endogenous force regulation of endothelial cell behavior | Q37611245 | ||
| Hypoxia-driven angiogenesis: role of tip cells and extracellular matrix scaffolding. | Q37716522 | ||
| Quantitative multi-gene transcriptional profiling using real-time PCR with a master template | Q40422373 | ||
| Functionally distinct human marrow stromal cell lines immortalized by transduction with the human papilloma virus E6/E7 genes. | Q41369475 | ||
| Microfabricated poly(ethylene glycol) templates enable rapid screening of triculture conditions for cardiac tissue engineering | Q42813852 | ||
| Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces | Q43893196 | ||
| Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts | Q47307807 | ||
| In vitro formation of capillary networks using optical lithographic techniques. | Q51001550 | ||
| Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. | Q52896306 | ||
| P433 | issue | 9-10 | |
| P304 | page(s) | 1219-1228 | |
| P577 | publication date | 2011-02-02 | |
| P1433 | published in | Tissue Engineering. Part A | Q15758518 |
| P1476 | title | Developing vasculature and stroma in engineered human myocardium | |
| P478 | volume | 17 |
| Q90481195 | A New Era of Cardiac Cell Therapy: Opportunities and Challenges |
| Q87939445 | A role for proteoglycans in vascular disease |
| Q51748407 | Activation of the unfolded protein response downregulates cardiac ion channels in human induced pluripotent stem cell-derived cardiomyocytes. |
| Q36800040 | Analysis of stromal cell secretomes reveals a critical role for stromal cell-derived hepatocyte growth factor and fibronectin in angiogenesis |
| Q35386835 | Capillary-like network formation by human amniotic fluid-derived stem cells within fibrin/poly(ethylene glycol) hydrogels |
| Q91936572 | Dual stem cell therapy synergistically improves cardiac function and vascular regeneration following myocardial infarction |
| Q33651561 | Embryonic origins of human vascular smooth muscle cells: implications for in vitro modeling and clinical application |
| Q38540150 | Engineered Tissue Patch for Cardiac Cell Therapy |
| Q27303626 | Enhanced Electrical Integration of Engineered Human Myocardium via Intramyocardial versus Epicardial Delivery in Infarcted Rat Hearts |
| Q60926710 | Generation of pancreatic β cells for treatment of diabetes: advances and challenges |
| Q38211168 | Heart regeneration with engineered myocardial tissue |
| Q98158955 | Human Cardiac Fibroblast Number and Activation State Modulate Electromechanical Function of hiPSC-Cardiomyocytes in Engineered Myocardium |
| Q47876397 | Human Schwann cells exhibit long-term cell survival, are not tumorigenic and promote repair when transplanted into the contused spinal cord |
| Q36857939 | Human placental multipotent mesenchymal stromal cells modulate placenta angiogenesis through Slit2-Robo signaling |
| Q37171447 | Human vasculogenic cells form functional blood vessels and mitigate adverse remodeling after ischemia reperfusion injury in rats |
| Q50452815 | In situ vascularization of injectable fibrin/poly(ethylene glycol) hydrogels by human amniotic fluid-derived stem cells. |
| Q47819879 | Inspiration from heart development: Biomimetic development of functional human cardiac organoids |
| Q49684144 | Integrated approaches to spatiotemporally directing angiogenesis in host and engineered tissues |
| Q43276365 | Mechanical Stress Conditioning and Electrical Stimulation Promote Contractility and Force Maturation of Induced Pluripotent Stem Cell-Derived Human Cardiac Tissue. |
| Q54691127 | Novel in vitro cardiovascular constructs composed of vascular-like networks and cardiomyocytes. |
| Q64038731 | Optimizing Blended Collagen-Fibrin Hydrogels for Cardiac Tissue Engineering with Human iPSC-derived Cardiomyocytes |
| Q33875374 | Pluripotent stem cell derived cardiomyocytes for cardiac repair |
| Q39069601 | Possible Muscle Repair in the Human Cardiovascular System |
| Q39033619 | Provisional matrix: A role for versican and hyaluronan |
| Q30563310 | SLIT3-ROBO4 activation promotes vascular network formation in human engineered tissue and angiogenesis in vivo |
| Q30746389 | Stromal Cells in Dense Collagen Promote Cardiomyocyte and Microvascular Patterning in Engineered Human Heart Tissue |
| Q36374351 | The effect of controlled expression of VEGF by transduced myoblasts in a cardiac patch on vascularization in a mouse model of myocardial infarction |
| Q34347650 | Trends in cardiovascular engineering: organizing the human heart |
| Q41763012 | Vascular Perfusion of Implanted Human Engineered Cardiac Tissue |
| Q91712036 | Versican-A Critical Extracellular Matrix Regulator of Immunity and Inflammation |
Search more.